Capital-Market Funding as an Option for New-Business Investment and Strengthening Equity
First written in FY2016-Q3. 3 of 8 entries say "Advanced", first in FY2026-H1. Latest entry: 2026-10-15.
Mani moved to the "Worse" side of this theme in 2019, 7 years before the typical company in this theme (2026).
91 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「On 22 December 2025, the Company acquired 36.67% of the issued equity interests from a major investor in iRIS, a German ophthalmic products distributor, and entered into an equity transfer agreement to make iRIS an equity-method affiliate.」
Regarding growth investment and capital allocation, the Company states that it entered into an agreement to acquire a 36.67% interest in iRIS, a German ophthalmic products distributor, and made an investment to strengthen its European sales structure. - FY2025RaisedAnnual report
「For growth investments, the Company will shift its focus from production investments centered on smart factories to growth investments aimed at enhancing corporate value, including M&A investments, for which an investment budget of ¥20 billion is envisaged.」
The Company is broadening its capital allocation focus from funding operations centered on internal funds and capital expenditures to growth investments through the fiscal year ending August 2029, including a ¥20 billion M&A investment budget. - FY2024ReframedAnnual report
「Although working capital and capital expenditures are funded with internal funds, the Company has entered into an overdraft agreement with its financial institutions for a total amount of ¥800 million to ensure flexibility and stability in financing.」
The explanation has shifted from the previous description of capital-market financing as an option to one in which internal funds are the primary source, with a ¥800 million overdraft agreement used to ensure financing flexibility and stability. - FY2019ReframedAnnual report
「In terms of sources of capital and liquidity, working capital and capital expenditures are funded with internal funds.」
While previously describing capital-market financing as an option, the Company explains that working capital and capital expenditures for the current year are funded with internal funds. - FY2016RestatedAnnual report
「The Company considers financing in the capital markets one option for raising funds to invest in new businesses that will contribute to expanding its business areas over the medium to long term, or for strengthening shareholders' equity」
The Company continues to regard capital-market financing as an option for investing in new businesses and strengthening shareholders' equity. - FY2016-Q3First statedAnnual report
「The Company considers financing in the capital markets one option for raising funds to invest in new businesses that will contribute to expanding its business areas over the medium to long term, or for strengthening shareholders' equity」
The Company considers capital-market financing an option for investing in new businesses or strengthening shareholders' equity.